|
rs1860661
|
|
Hodgkin Disease
|
|
0.810 |
GeneticVariation
|
BEFREE |
We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR)=0.81, 95% confidence interval (95% CI) = 0.76-0.86, P(combined) = 3.5 × 10(-10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis.
|
24920014 |
2014 |
|
rs1860661
|
|
Hodgkin Disease
|
|
0.810 |
GeneticVariation
|
GWASDB |
We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR)=0.81, 95% confidence interval (95% CI) = 0.76-0.86, P(combined) = 3.5 × 10(-10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis.
|
24920014 |
2014 |
|
rs1860661
|
|
Hodgkin Disease
|
|
0.810 |
GeneticVariation
|
GWASCAT |
We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR)=0.81, 95% confidence interval (95% CI) = 0.76-0.86, P(combined) = 3.5 × 10(-10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis.
|
24920014 |
2014 |
|
rs20541
|
|
Hodgkin Disease
|
A |
0.810 |
GeneticVariation
|
GWASDB |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
|
rs20541
|
|
Hodgkin Disease
|
|
0.810 |
GeneticVariation
|
BEFREE |
We searched for an association between the interleukin 4 receptor gene (IL4R) rs1805015 and interleukin 13 gene (IL13) rs20541 polymorphisms and the development of antibodies to hepatitis B surface antigen (anti-HBs) in the case of hepatitis B virus (HBV) vaccination or infection in hemodialysis (HD) patients.
|
23462527 |
2013 |
|
rs20541
|
|
Hodgkin Disease
|
|
0.810 |
GeneticVariation
|
GWASDB |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
|
rs20541
|
|
Hodgkin Disease
|
|
0.810 |
GeneticVariation
|
GWASCAT |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
|
rs1432295
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
|
rs1432295
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
|
rs1432295
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
|
rs1432295
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
|
rs2019960
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
|
rs2019960
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASDB |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
|
rs2019960
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
|
rs2019960
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
|
rs2019960
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
|
rs2019960
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |
|
rs2069757
|
|
Hodgkin Disease
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
|
rs2069757
|
|
Hodgkin Disease
|
A |
0.800 |
GeneticVariation
|
GWASDB |
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.
|
24920014 |
2014 |
|
rs2248462
|
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
|
rs2248462
|
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
|
rs2395185
|
|
Hodgkin Disease
|
C |
0.800 |
GeneticVariation
|
GWASDB |
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
|
24149102 |
2013 |
|
rs2395185
|
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
|
rs2395185
|
|
Hodgkin Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
|
22286212 |
2012 |
|
rs2608053
|
|
Hodgkin Disease
|
G |
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).
|
21037568 |
2010 |